Evidence map›Paper›PMID 42634594›Full record

ArticleMedical physics2026

Performance evaluation of a dedicated brain PET scanner with octagonal detector arrangement using a modified NEMA NU2 2018 protocol.

Ekaterina Mikhaylova, Max L Ahnen, Henryk Barthel, Jan Debus, Jannis Fischer, Martin Huellner, Markus Jehl, Philipp A Kaufmann, Michael Rullmann, Bernhard Sattler and 6 more

Abstract readEvaluation Study
In one paragraph

Article in Medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ekaterina MikhaylovaPositrigo, Technoparkstrasse, Zurich, Switzerland.
Max L AhnenPositrigo, Technoparkstrasse, Zurich, Switzerland.
Henryk BarthelDepartment of Nuclear Medicine, University of Leipzig Medical Center, Leipzig, Germany.
Jan DebusPositrigo, Technoparkstrasse, Zurich, Switzerland.
Jannis FischerPositrigo, Technoparkstrasse, Zurich, Switzerland.
Martin HuellnerDepartment of Nuclear Medicine, University Hospital Zurich/University of Zurich, Zurich, Switzerland.
Markus JehlPositrigo, Technoparkstrasse, Zurich, Switzerland.
Philipp A KaufmannDepartment of Nuclear Medicine, University Hospital Zurich/University of Zurich, Zurich, Switzerland.
Michael RullmannDepartment of Nuclear Medicine, University of Leipzig Medical Center, Leipzig, Germany.
Bernhard SattlerDepartment of Nuclear Medicine, University of Leipzig Medical Center, Leipzig, Germany.
Karen G SteinhoffDepartment of Nuclear Medicine, University of Leipzig Medical Center, Leipzig, Germany.
Juan StrebPositrigo, Technoparkstrasse, Zurich, Switzerland.
Solveig TiepoltDepartment of Nuclear Medicine, University of Leipzig Medical Center, Leipzig, Germany.
Valerie TreyerDepartment of Nuclear Medicine, University Hospital Zurich/University of Zurich, Zurich, Switzerland.
Osama SabriDepartment of Nuclear Medicine, University of Leipzig Medical Center, Leipzig, Germany.
Ilaria SaccoPositrigo, Technoparkstrasse, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis work presents the NEMA NU2 2018 performance evaluation of the NeuroLF Basic, a compact and fully integrated brain positron emission tomography (PET) system based on 10-mm-long LYSO crystals. PURPOSE: The goal is to assess its quantitative performance and imaging capabilities for neuroimaging applications.

methodsThe evaluation includes measurements and simulations of spatial resolution, scatter fraction, noise equivalent count rate (NECR), accuracy of corrections, image quality, and sensitivity, following standardized protocols to ensure reliable and reproducible results. In addition, imaging of the Hoffman 3-dimensional brain phantom was performed to visually evaluate system performance. Image quality was assessed using an ACR Esser phantom, which fits within the compact bore of the NeuroLF scanner.

resultsThe average filtered-back-projection spatial resolution, measured at 1 and 10 cm radial offsets, was 2.51 and 3.61 mm, respectively, highlighting the system's ability to capture details essential for neuroimaging. The scatter fraction was 24.2% at the peak NECR, reflecting the system's capability to minimize scattered events. The peak NECR was 55.3 kcps at an activity concentration of 8.1 kBq/mL, demonstrating the system's efficiency in handling typical neuroimaging count rates. NeuroLF showed excellent accuracy of corrections at 3.7% and good image contrast for hot vials in a warm background in the adapted image quality procedure with the ACR Esser phantom, achieving values of 87.5%, 77%, 60%, and 35.8% for 25-, 16-, 12-, and 8-mm-diameter vials, respectively, with a maximum background variability of 10% for the 8-mm vial. Sensitivity, evaluated using a 70-cm line source, was 5.85 cps/kBq at the center of the field of view and 8.08 cps/kBq at a 10 cm radial offset. Images of the Hoffman phantom further demonstrated the system's ability to produce realistic brain uptake distributions. The measured NEMA NU2 2018 results showed good agreement with Monte Carlo simulation results, validating the simulated NeuroLF model for future research and optimization.

conclusionsThese results demonstrate the NeuroLF's potential to deliver high-quality images, good detection efficiency, and robust quantitative performance. The comprehensive NEMA NU2 2018 evaluation, supported by Hoffman phantom imaging, confirms NeuroLF's capability as a valuable tool for clinical applications in neuroimaging.

Indexed as

BrainPositron-Emission TomographyImage Processing, Computer-AssistedPhantoms, ImagingSignal-To-Noise Ratiobrain PETGATE simulationsNEMA NU2 2018performance evaluation

Identifiers

PMID42634594
PMCPMC13501193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.